Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Healthcare Biotechnology
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Unaware of Any Material Change

Business Wire April 18, 2018

Covalon to Feature MediClear™ PreOp at AORN Surgical Conference and Expo 2018

Business Wire March 26, 2018

Covalon Announces Voting Results from 2018 Annual Meeting of Shareholders

Business Wire March 9, 2018

Covalon’s MediClear™ PreOp Receives Frost & Sullivan’s 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Business Wire March 5, 2018

Covalon Annual Shareholders’ Meeting to be Held Thursday March 8th 2018 at 3:30pm EST

Business Wire March 1, 2018

Covalon Announces its Participation in Medical Japan 2018

Business Wire February 20, 2018

Covalon Announces Strong First Quarter Financial Results

Business Wire February 12, 2018

Covalon Announces Conference Call to Discuss Q1 Financial Results

Business Wire February 9, 2018

Covalon to Showcase Centaur™ Low Particulate, Lubricious Coating at MD&M West

Business Wire February 5, 2018

Covalon Announces Issuance of Stock Options

Business Wire January 24, 2018

Covalon Announces Issuance of Stock Options

Business Wire December 21, 2017

Covalon Announces Record Positive Results for Fiscal 2017

Business Wire December 18, 2017

US Major General Gale S. Pollock (Ret.) Joins Covalon’s Board of Directors

Business Wire November 14, 2017

Covalon Announces Issuance of Stock Options

Business Wire October 27, 2017

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire October 13, 2017

Covalon to Feature its Advanced Wound Management and Infection Prevention Lines at Limb Salvage and Woundcare Symposium

Business Wire October 5, 2017

Covalon Announces Major Milestone: FDA Clearance for MediClear™ PreOp

Business Wire September 21, 2017

Covalon Announces the Commencement of Trading on the OTCQX Market in the United States

Business Wire September 18, 2017

OTC Markets Group Welcomes Covalon Technologies to OTCQX

PR Newswire September 18, 2017

Covalon Announces $14 Million in New Contract Orders in the Middle East

Business Wire September 5, 2017